« Back
SuperScript® IV Reverse Transcriptase: A New Reverse Transcriptase for RNA Analysis
SuperScript® IV Reverse Transcriptase: A New Reverse Transcriptase for RNA Analysis
Submitted on 16 Oct 2018

Bianca J Lam1 , Kevin Zhang1 , Joanna Guo1 , Lushen Li 1 , Kimberly Wong Garcia 1 , Asta Jokubauskaite 2 , Milda Kaniusaite2 , Tomas Radzvilavicius2 , and Arunas Lagunavicius 2

Poster Views: 226
View poster »
Poster Abstract
Survey and interview studies conducted over a three year
period revealed that researchers are not satisfied with their
current reverse transcriptase and are performing reactions
with increasingly difficult samples, such as poorly purified
RNA and unpurified RNA (direct RT) that both contain
inhibitors. To meet this performance gap, the Thermo Fisher
Life Sciences Solutions group produced a new reverse
transcriptase, SuperScript® IV, and experiments we
performed show that it is the most robust reverse
transcriptase compared to other enzymes. SuperScript® IV
characterization was performed in the context of “real
world” situations where users do not have perfect RNA
samples. In the presence of a variety of inhibitors, we
demonstrate that SuperScript® IV possesses superior
performance in a variety of inhibitors, such as alcohols,
salts, detergents, phenol, heparin, hematin, bile salts, and
formalin typically found in sample preparation reagents, cell
lines, blood, feces, and FFPE samples. This enzyme can
even detect RNA targets in unpurified RNA samples
(directly lysed cells) and whole blood without sacrificing
sensitivity and yield. The introduction of SuperScript® IV
enables researchers to obtain more consistent results
independent of sample quality and simplify and speed up
workflows by eliminating RNA purification.

We would like to thank Toby Jordan and Samantha Li for their
work and support in the development of SuperScript®IV
Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

Localisation of HN Gene Expression of NDV-AF2240 in Brain of 4T1 Induced Breast Cancer BALB/c mice
Umar Ahmad, Gholamreza Motalleb, Asmah Rahmat, Fauziah Othman, & Aini Ideris

The EurOPDX EDIReX project: towards a European Research Infrastructure on patient-derived cancer models
E. Vinolo 1, J.P. Morris 1, D.G. Alférez 2, J. Arribas 3,4,5, C. Bernadó 3,4,5, A. Bertotti 6, A. Bruna 7, A.T. Byrne 8, C. Caldas 7, R.B. Clarke 2, N. Conte 9, R. Corsi 10, S. Corso 6, M. Crespo 3, A. Dahmani 11, V. Dangles-Marie 11, D. Decaudin 11, Z. Dudová 12, A. Fiori 6, S. Giordano 6, M. Hauptsmann 13, M. Hidalgo 14, C. Isella 6, S. de Jong 15, J. Jonkers 13, A. Křenek 12, O. Krijgsman 13, D. Kouřil 12, J.C. Lacal 14, L. Lanfrancone 16, E. Leucci 17, G.M. Mælandsmo 18, E. Marangoni 11, J. Mason 9, M.Th. Mayrhofer 19, A. Mazzocca 6, T.S. Meehan 9, E. Montaudon 11, F. Nem

G-Quadruplex Structures in Microbial DNA - A Role in Basic Biology and a Possible Antimicrobial Target: A Review of Recent Literature and a Proposal
Singh, Vikal and Leifer, Zev

Platinum™ II Taq Hot-Start DNA Polymerase: PCR simplified with universal annealing
Skaistė Valinskytė, Edita Elijošiūtė, Tomas Radzvilavičius, Miglė Mikutėnaitė, Jonas Belevičius, Aistė Serapinaitė, Rasa Sukackaitė

Single-use technology in the production of DNA-free Taq DNA polymerase
Kęstutis Bargaila, Vytautas, Budrys, Andrius Krasauskas, Dovilė Lisauskienė, Milda Romeikaitė, Sonata J.-Urbanavičienė, and Juozas Šiurkus